Amelioration of oxidative stress and insulin resistance by soy isoflavones (from Glycine max) in ovariectomized Wistar rats fed with high fat diet: The molecular mechanisms

Experimental Gerontology

Volumn 63, Issue , 2015, Pages 67-75

  Sankar, P ^a   Zachariah, Bobby ^a   Vickneshwaran, V ^a   Jacob, Sajini Elizabeth ^a   Sridhar, M G ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Insulin resistance; Ovariectomy; Oxidative stress; Soy isoflavones

Indexed keywords

BETA ACTIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE 1; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; ISOFLAVONE DERIVATIVE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; ANTIOXIDANT; INSULIN; PHYTOESTROGEN; SLC2A4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; IMMUNOBLOTTING; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; MOLECULAR DYNAMICS; NONHUMAN; OVARIECTOMY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; LIVER; METABOLISM; SOYBEAN; WISTAR RAT;

GLYCINE MAX; RATTUS; RATTUS NORVEGICUS;

ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; DIET, HIGH-FAT; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; LIVER; OVARIECTOMY; OXIDATIVE STRESS; PHYTOESTROGENS; RATS; RATS, WISTAR; SOYBEANS;

EID: 84922709089     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.02.001     Document Type: Article

References (41)

1. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002, 3:364-373.
2. Aguirre V., Uchida T., Yenush L., Davis R., White M.F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 2000, 275:9047-9054.
3. Altenhöfer S., Kleikers P.W.M., Radermacher K.A., Scheurer P., Rob Hermans J.J., Schiffers P., Ho H., Wingler K., Schmidt H.H.H.W. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell. Mol. Life Sci. 2012, 69:2327-2343. 10.1007/s00018-012-1010-9.
4. BEUTLER E., DURON O., KELLY B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963, 61:882-888.
5. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic. Biol. Med. 2009, 47:1239-1253. 10.1016/j.freeradbiomed.2009.07.023.
6. Carlson C.J., Koterski S., Sciotti R.J., Poccard G.B., Rondinone C.M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 2003, 52:634-641.
7. De Fea K., Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J. Biol. Chem. 1997, 272:31400-31406.
8. De Kleijn M.J.J., van der Schouw Y.T., Wilson P.W.F., Grobbee D.E., Jacques P.F. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S.women: the Framingham study. J. Nutr. 2002, 132:276-282.
9. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112. 10.1146/annurev.bi.64.070195.000525.
10. Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., Onishi Y., Ono H., Funaki M., Inukai K., Fukushima Y., Kikuchi M., Oka Y., Asano T. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J. Biol. Chem. 2001, 276:19800-19806. 10.1074/jbc.M101087200.
11. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 2004, 151:657-687.
12. Grygiel-Górniak B., Marcinkowska J., Szczepanik A., Przysławski J. The nutritional and oxidative stress implications of postmenopausal age. Pol. Arch. Med. Wewn. 2014, 124(6):298-305.
13. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997, 350:990-994. 10.1016/S0140-6736(97)01339-1.
14. Jaimes E.A., Galceran J.M., Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 1998, 54:775-784. 10.1046/j.1523-1755.1998.00068.x.
15. Lee Y.-B., Lee H.J., Kim K.S., Lee J.-Y., Nam S.-Y., Cheon S.-H., Sohn H.-S. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 2004, 68:1040-1045.
16. Lenda D.M., Boegehold M.A. Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H395-H402. 10.1152/ajpheart.00354.2001.
17. Lethaby A., Marjoribanks J., Kronenberg F., Roberts H., Eden J., Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst. Rev. 2013, 12:CD001395. 10.1002/14651858.CD001395.pub4.
18. Li N., Yi F.-X., Spurrier J.L., Bobrowitz C.A., Zou A.-P. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am. J. Physiol. Ren. Physiol. 2002, 282:F1111-F1119. 10.1152/ajprenal.00218.2001.
19. Lindheim S.R., Buchanan T.A., Duffy D.M., Vijod M.A., Kojima T., Stanczyk F.Z., Lobo R.A. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J. Soc. Gynecol. Investig. 1994, 1:150-154.
20. Liu Z., Zhang X., Li L., Zhang W., Cui W., Song Y., Wang W., Jia X., Li N., Yan W. Effects of lactational exposure to soy isoflavones on reproductive system in neonatal female rats. Basic Clin. Pharmacol. Toxicol. 2008, 102:317-324. 10.1111/j.1742-7843.2007.00172.x.
21. LOWRY O.H., ROSEBROUGH N.J., FARR A.L., RANDALL R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
22. Margolis K.L., Bonds D.E., Rodabough R.J., Tinker L., Phillips L.S., Allen C., Bassford T., Burke G., Torrens J., Howard B.V., Women's Health Initiative Investigators Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004, 47:1175-1187. 10.1007/s00125-004-1448-x.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Miller V.M., Duckles S.P. Vascular actions of estrogens: functional implications. Pharmacol. Rev. 2008, 60:210-241. 10.1124/pr.107.08002.
25. Parada B., Reis F., Figueiredo A., Nunes P., Teixeira-Lemos E., Garrido P., Sereno J., Pinto R., Cunha M.F.X., Neto P., Santos P., Velada I., Mota A., Teixeira F. Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model. BJU Int. 2011, 107:135-143. 10.1111/j.1464-410X.2010.09326.x.
26. Pendyala S., Natarajan V. Redox regulation of Nox proteins. Respir. Physiol. Neurobiol. 2010, 174:265-271. 10.1016/j.resp.2010.09.016.
27. Qiao L.Y., Goldberg J.L., Russell J.C., Sun X.J. Identification of enhanced serine kinase activity in insulin resistance. J. Biol. Chem. 1999, 274:10625-10632.
28. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150:2161-2168. 10.1210/en.2008-1405.
29. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. Writing Group for the Women's Health Initiative Investigators.
30. Sánchez-Rodríguez M.A., Zacarías-Flores M., Arronte-Rosales A., Correa-Muñoz E., Mendoza-Núñez V.M. Menopause as risk factor for oxidative stress. Menopause 2012, 19:361-367. 10.1097/gme.0b013e318229977d.
31. Shapiro Y., Mashavi M., Luckish E., Shargorodsky M. Diabetes and menopause aggravate age-dependent deterioration in arterial stiffness. Menopause 2014, 10.1097/GME.0000000000000231.
32. Sternfeld, Pimenta Filipa, Maroco João, Ramos Catarina, Leal Isabel Predictors of weight variation and weight gain in peri- and post-menopausal women. J. Health Psychol. 2005, 19(8):993-1002.
33. Storlien L.H., James D.E., Burleigh K.M., Chisholm D.J., Kraegen E.W. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am. J. Physiol. 1986, 251:E576-E583.
34. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991, 352:73-77. 10.1038/352073a0.
35. Unni J. Third consensus meeting of Indian Menopause Society (2008): a summary. J. Midlife Health 2010, 1:43-47. 10.4103/0976-7800.66987.
36. Van der Schouw Y.T., Pijpe A., Lebrun C.E.I., Bots M.L., Peeters P.H.M., van Staveren W.A., Lamberts S.W.J., Grobbee D.E. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1316-1322.
37. Wellons M., Ouyang P., Schreiner P.J., Herrington D.M., Vaidya D. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis (MESA). Menopause 2012, 19:1081-1087. 10.1097/gme.0b013e3182517bd0.
38. White R.E., Gerrity R., Barman S.A., Han G. Estrogen and oxidative stress: a novel mechanism that may increase the risk for cardiovascular disease in women. Steroids 2010, 75:788-793. 10.1016/j.steroids.2009.12.007.
39. Yagi K. Assay for blood plasma or serum. Methods Enzymol. 1984, 105:328-331.
40. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787. 10.1038/414782a.
41. Zou A.P., Li N., Cowley A.W. Production and actions of superoxide in the renal medulla. Hypertension 2001, 37:547-553.